A Medical Friend in Lanka: “In response to Dr Justin Labrooy’s email about Ivermectin usage: I totally agree that people should not self-medicate. It can be very dangerous.”
Dr Peter McCullough MD, testified to the Texas Senate HHS Committee. He has done a lot of work on early treatment of Covid. He found the best treatment to be sequential multidrug treatment, one drug alone does not seem to work.
https://www.youtube.com/watch?app=desktop&v=QAHi3lX3oGM
Peter McCullough, MD testifies to Texas Senate HHS Committee …. LISTEN
2,063,266 views …………….Mar 12, 2021
This is the research paper he mentions: https://rcm.imrpress.com/article/2020/2153-8174/RCM2020264.shtml
Abstract
The SARS-CoV-2 virus spreading across the world has led to surges of COVID-19 illness, hospitalizations, and death. The complex and multifaceted pathophysiology of life-threatening COVID-19 illness including viral mediated organ damage, cytokine storm, and thrombosis warrants early interventions to address all components of the devastating illness. In countries where therapeutic nihilism is prevalent, patients endure escalating symptoms and without early treatment can succumb to delayed in-hospital care and death. Prompt early initiation of sequenced multidrug therapy (SMDT) is a widely and currently available solution to stem the tide of hospitalizations and death. A multipronged therapeutic approach includes 1) adjuvant nutraceuticals, 2) combination intracellular anti-infective therapy, 3) inhaled/oral corticosteroids, 4) antiplatelet agents/anticoagulants, 5) supportive care including supplemental oxygen, monitoring, and telemedicine. Randomized trials of individual, novel oral therapies have not delivered tools for physicians to combat the pandemic in practice. No single therapeutic option thus far has been entirely effective and therefore a combination is required at this time. An urgent immediate pivot from single drug to SMDT regimens should be employed as a critical strategy to deal with the large numbers of acute COVID-19 patients with the aim of reducing the intensity and duration of symptoms and avoiding hospitalization and death.
Keywords: SARS-CoV-2; COVID-19; hospitalization; mortality; ambulatory treatment; anti-infective; anti-inflammatory; antiviral; corticosteroid; antiplatelet agent; anticoagulant; sequenced multidrug therapy
ALSO SEE https://www.uscjournal.com/authors/peter-mccullough
https://lymediseaseassociation.org/about-lyme/research-articles/peter-a-mccullough-md-mph-covid-19-treatment-protocols/
Like this:
Like Loading...
